Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

While current international guidelines include imaging of the target lesion for response
monitoring in metastatic breast cancer, they do not provide specific recommendations for …

Response evaluation at regular intervals is indicated for treatment of metastatic breast
cancer (MBC). FDG-PET/CT has the potential to monitor treatment response accurately. Our …

This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

This study aimed to compare contrast-enhanced CT (CE-CT) and 18F-FDG PET/CT for
response monitoring in metastatic breast cancer using the standardized response …

The PET Response Criteria in Solid Tumors (PERCIST) are not specific regarding the
number of lesions that should be analyzed per patient. This study evaluated how the number …

Simple Summary The method of treatment evaluation in patients with chronic breast cancer
may affect clinical decision making and treatment protocols. In this study, we compared the …

Purpose The aim of this study was to compare fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) and contrast-enhanced computed …

18F-fluorodeoxyglucose positron emission tomography with integrated computed
tomography (FDG-PET/CT) and contrast-enhanced computed tomography (CT) can be used …

Background We compared overall survival for metastatic breast cancer (MBC) patients
monitored with CE-CT, FDG-PET/CT or a combination of them in an observational setting …